MaxCyte Inc.

NASDAQ: MXCT · Real-Time Price · USD
1.38
-0.03 (-2.13%)
At close: Aug 15, 2025, 12:53 PM

MaxCyte Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
38.63M 41.29M 44.26M 33.89M
Cost of Revenue
7.1M 4.74M 5.1M 3.65M
Gross Profit
31.53M 36.55M 39.16M 30.25M
Operating Income
-51.2M -48.3M -27.36M -18.19M
Interest Income
10.14M 10.38M 3.92M 150.8K
Pretax Income
-41.05M -37.92M -23.57M -19.08M
Net Income
-41.05M -37.92M -19.78M -20.13M
Selling & General & Admin
56.35M 57.04M 44.48M 31.68M
Research & Development
22.23M 23.82M 19.51M 15.41M
Other Expenses
4.14M 3.98M 2.53M 1.35M
Operating Expenses
78.44M 84.84M 66.52M 48.44M
Interest Expense
n/a n/a 126.9K 1.04M
Selling & Marketing Expenses
26.66M 26.98M 18.65M 13M
Cost & Expenses
89.82M 89.59M 71.62M 52.08M
Income Tax Expense
n/a n/a -3.79M 1.04M
Shares Outstanding (Basic)
104.85M 103.27M 101.7M 90.62M
Shares Outstanding (Diluted)
104.85M 103.27M 101.7M 90.62M
EPS (Basic)
-0.39 -0.37 -0.19 -0.22
EPS (Diluted)
-0.39 -0.37 -0.19 -0.22
EBITDA
-46.41M -44.13M -20.87M -16.76M
EBIT
-51.2M -48.3M -27.36M -18.04M
Depreciation & Amortization
4.79M 4.17M 2.7M 1.42M